Cancer Diagnosis news and technical articles from BioOptics World. Search Cancer Diagnosis latest and archived news and articles
Recent developments in optical coherence tomography (OCT) address skin cancer diagnosis . MedLumics (Madrid, Spain) has launched a three-year initiative to translate research into new clinical applications—with
analyze freshly cut human breast tissue samples for certain histological parameters that are typically used in breast cancer diagnosis . The software uses the parameter data to classify the tissue in each image and make a determination whether the
tissue during operation, as well as reduce unnecessary surgery. Related: Biophotonics enables early and accurate cancer diagnosis The research team, led by Ioan Notingher, Ph.D., an associate professor in the School of Physics and Astronomy
Nanotechnology is at the basis of a new initiative and a recently announced discovery, both originating in Europe.
Cancer tests are so expensive that they are administered only when there is compelling evidence of disease potential.
years, incidence rates have increased more than any other cancers in the UK. Successful treatment relies on early cancer diagnosis , so developing an automated scanning method that avoids the need to take biopsies is high on the research agenda
DECEMBER 5, 2008--SpectraScience Inc. (San Diego, CA) has been awarded a European patent for its optical biopsy system, which targets tissue diagnosis and reliable cancer screening. The patent supports SpectraScience's technology for use of non-invasive, low-level lasers to diagnose pre-malignant
SEPTEMBER 19, 2008 -- SpectraScience, Inc. (San Diego, CA), has shipped its WavSTAT Optical Biopsy System to both the Mayo Clinic and the University of California San Diego/VA to complete the final phase of a three-year study. The clinics will test the optical biopsy system as an adjunctive ...
An in vivo molecular diagnostic system has proven clinically capable of real-time pre- cancer diagnosis during gastrointestinal endoscopy. 1 While conventional endoscopy relies on an individual doctor's "eyeballing" followed by
that the test is highly sensitive, very easy to use, and has the potential to provide major improvements in early cancer diagnosis . The test is based on nanotechnology called nanoDLSAY, and it claims to be the first test to use dynamic light